Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure

D J Beuckelmann1, M Näbauer, C Krüger

  • 1Department of Medicine III, University of Cologne, Germany.

Insights

In heart failure patients, the slow decline of intracellular calcium (Ca2+) in heart muscle is partly due to reduced calcium reuptake by the sarcoplasmic reticulum. Sarcolemmal Ca2+ ATPase plays a minor role in this process.

Area of Science:

  • Cardiology
  • Cell Physiology
  • Biochemistry

Background:

  • Diastolic dysfunction in heart failure is linked to altered intracellular calcium (Ca2+) handling.
  • The roles of sarcoplasmic reticulum Ca2+ ATPase and sarcolemmal Ca2+ ATPase in this dysfunction are not fully understood.

Purpose of the Study:

  • To determine if impaired Ca2+ adenosine triphosphatase (ATPase) function of the sarcoplasmic reticulum or sarcolemma contributes to slow diastolic Ca2+ decay in heart failure.
  • To investigate the specific contributions of sarcoplasmic reticulum and sarcolemmal Ca2+ removal mechanisms.

Main Methods:

  • Ventricular myocytes were isolated from human hearts with terminal heart failure and from healthy donors.
  • Intracellular Ca2+ ([Ca2+]i) transients were measured using voltage-clamp techniques.
  • To isolate sarcoplasmic reticulum Ca2+ reuptake, Na+/Ca2+ exchange was inhibited, and sarcoplasmic reticulum was loaded with Ca2+ via voltage-clamp pulses.

Main Results:

  • Diastolic [Ca2+]i decay was significantly slower in myocytes from heart failure patients (538 msec) compared to controls (305 msec).
  • Caffeine application, which inhibits sarcoplasmic reticulum Ca2+ reuptake, abolished significant [Ca2+]i decay in both groups, indicating sarcoplasmic reticulum involvement.
  • Sarcolemmal Ca2+ ATPase activity did not significantly impact [Ca2+]i removal during individual heartbeats.

Conclusions:

  • Decreased Ca2+ reuptake by the sarcoplasmic reticulum is a significant factor contributing to the slow diastolic [Ca2+]i decay observed in heart failure.
  • Sarcolemmal Ca2+ ATPase is not a major contributor to cytoplasmic [Ca2+]i removal during the cardiac cycle in the context of heart failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...